Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Regenxbio Inc banner

Regenxbio Inc
SWB:RB0

Watchlist Manager
Regenxbio Inc Logo
Regenxbio Inc
SWB:RB0
Watchlist
Price: 9.73 EUR 7.94%
Market Cap: €813.7m
Write Note Create Alert Ask AI

Wall St Price Targets

RB0 Price Targets Summary
Regenxbio Inc

Wall Street analysts forecast RB0 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RB0 is 23.37 EUR with a low forecast of 8.9 EUR and a high forecast of 46.27 EUR.

RB0 Lowest Forecast
Wall Street Target
€8.9
-9% Downside
RB0 Average Forecast
Wall Street Target
€23.37
140% Upside
RB0 Highest Forecast
Wall Street Target
€46.27
376% Upside
Lowest Forecast
Price Target
8.9 EUR
9% Downside
Average Forecast
Price Target
23.37 EUR
140% Upside
Highest Forecast
Price Target
46.27 EUR
376% Upside
Regenxbio Inc Competitors:
Price Targets
PTCT
PTC Therapeutics Inc
39% Upside
SMCP
SMCP SA
40% Upside
PTCT
PTC Therapeutics Inc
39% Upside
SMCP
SMCP SA
40% Upside

Revenue
Forecast

35% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
35% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Over the last 11 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 30%.

What are analyst estimates?

Gross Profit
Forecast

36% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
36% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Over the last 11 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 8 years is 30%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

What are analyst estimates?

Continue RB0 Research

Summary
RB0 intrinsic value, competitors valuation, and company profile.
DCF Valuation
RB0 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RB0 stock valuation using valuation multiples.
Wall St Estimates
RB0 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RB0 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Regenxbio Inc listings:
NASDAQ • USD
RGNX
 F • EUR
RB0
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RB0's stock price target?
Price Target
23.37 EUR

According to Wall Street analysts, the average 1-year price target for RB0 is 23.37 EUR with a low forecast of 8.9 EUR and a high forecast of 46.27 EUR.

What is the Revenue forecast for Regenxbio Inc?
Projected CAGR
30%

Over the last 11 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 30%.

What is the Gross Profit forecast for Regenxbio Inc?
Projected CAGR
30%

Over the last 11 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 8 years is 30%.

Back to Top
ALPHA SPREAD
Follow us
Join 353,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett